BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

697 related articles for article (PubMed ID: 20000886)

  • 1. Augmented renal clearance: implications for antibacterial dosing in the critically ill.
    Udy AA; Roberts JA; Boots RJ; Paterson DL; Lipman J
    Clin Pharmacokinet; 2010; 49(1):1-16. PubMed ID: 20000886
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Augmented renal clearance in pediatric intensive care: are we undertreating our sickest patients?
    Dhont E; Van Der Heggen T; De Jaeger A; Vande Walle J; De Paepe P; De Cock PA
    Pediatr Nephrol; 2020 Jan; 35(1):25-39. PubMed ID: 30374606
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of hypoalbuminaemia on optimizing antibacterial dosing in critically ill patients.
    Ulldemolins M; Roberts JA; Rello J; Paterson DL; Lipman J
    Clin Pharmacokinet; 2011 Feb; 50(2):99-110. PubMed ID: 21142293
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ARC--augmented renal clearance.
    Udy AA; Putt MT; Boots RJ; Lipman J
    Curr Pharm Biotechnol; 2011 Dec; 12(12):2020-9. PubMed ID: 21554215
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Augmented Renal Clearance in Critically Ill Patients: A Systematic Review.
    Bilbao-Meseguer I; Rodríguez-Gascón A; Barrasa H; Isla A; Solinís MÁ
    Clin Pharmacokinet; 2018 Sep; 57(9):1107-1121. PubMed ID: 29441476
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Personalized application of antimicrobial drugs in pediatric patients with augmented renal clearance: a review of literature.
    Xu WX; Qu Q; Teng XQ; Zhuang HH; Liu SF; Wang Y; Qu J
    Eur J Pediatr; 2024 Jan; 183(1):51-60. PubMed ID: 37861791
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Implications of Augmented Renal Clearance on Drug Dosing in Critically Ill Patients: A Focus on Antibiotics.
    Hobbs AL; Shea KM; Roberts KM; Daley MJ
    Pharmacotherapy; 2015 Nov; 35(11):1063-75. PubMed ID: 26598098
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Augmented renal clearance in critically ill patients: etiology, definition and implications for beta-lactam dose optimization.
    Sime FB; Udy AA; Roberts JA
    Curr Opin Pharmacol; 2015 Oct; 24():1-6. PubMed ID: 26119486
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modified Augmented Renal Clearance score predicts rapid piperacillin and tazobactam clearance in critically ill surgery and trauma patients.
    Akers KS; Niece KL; Chung KK; Cannon JW; Cota JM; Murray CK
    J Trauma Acute Care Surg; 2014 Sep; 77(3 Suppl 2):S163-70. PubMed ID: 24770557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determining the mechanisms underlying augmented renal drug clearance in the critically ill: use of exogenous marker compounds.
    Udy AA; Jarrett P; Stuart J; Lassig-Smith M; Starr T; Dunlop R; Wallis SC; Roberts JA; Lipman J
    Crit Care; 2014 Nov; 18(6):657. PubMed ID: 25432141
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Substantial Impact of Altered Pharmacokinetics in Critically Ill Patients on the Antibacterial Effects of Meropenem Evaluated via the Dynamic Hollow-Fiber Infection Model.
    Bergen PJ; Bulitta JB; Kirkpatrick CMJ; Rogers KE; McGregor MJ; Wallis SC; Paterson DL; Nation RL; Lipman J; Roberts JA; Landersdorfer CB
    Antimicrob Agents Chemother; 2017 May; 61(5):. PubMed ID: 28264846
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Augmented Renal Clearance Using Population-Based Pharmacokinetic Modeling in Critically Ill Pediatric Patients.
    Avedissian SN; Bradley E; Zhang D; Bradley JS; Nazer LH; Tran TM; Nguyen A; Le J
    Pediatr Crit Care Med; 2017 Sep; 18(9):e388-e394. PubMed ID: 28640009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Implications of augmented renal clearance in critically ill patients.
    Udy AA; Roberts JA; Lipman J
    Nat Rev Nephrol; 2011 Jul; 7(9):539-43. PubMed ID: 21769107
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Using PK/PD to optimize antibiotic dosing for critically ill patients.
    Roberts JA
    Curr Pharm Biotechnol; 2011 Dec; 12(12):2070-9. PubMed ID: 21554211
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Research advances in augmented renal clearance in critically ill children].
    Zhou R; Fang YT; Su D
    Zhongguo Dang Dai Er Ke Za Zhi; 2019 Oct; 21(10):1055-1058. PubMed ID: 31642444
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Augmented renal clearance: a common condition in critically ill children.
    Van Der Heggen T; Dhont E; Peperstraete H; Delanghe JR; Vande Walle J; De Paepe P; De Cock PA
    Pediatr Nephrol; 2019 Jun; 34(6):1099-1106. PubMed ID: 30778827
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Are Antibiotics Appropriately Dosed in Critically Ill Patients with Augmented Renal Clearance? A Narrative Review.
    Sistanizad M; Hassanpour R; Pourheidar E
    Int J Clin Pract; 2022; 2022():1867674. PubMed ID: 35685541
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibacterial dosing in intensive care: pharmacokinetics, degree of disease and pharmacodynamics of sepsis.
    Roberts JA; Lipman J
    Clin Pharmacokinet; 2006; 45(8):755-73. PubMed ID: 16884316
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors of augmented renal clearance based on iohexol plasma clearance in critically ill children.
    Dhont E; Van Der Heggen T; Snauwaert E; Willems J; Croubels S; Delanghe J; De Waele JJ; Colman R; Vande Walle J; De Paepe P; De Cock PA
    Pediatr Nephrol; 2024 May; 39(5):1607-1616. PubMed ID: 37994980
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Augmented renal clearance in septic and traumatized patients with normal plasma creatinine concentrations: identifying at-risk patients.
    Udy AA; Roberts JA; Shorr AF; Boots RJ; Lipman J
    Crit Care; 2013 Feb; 17(1):R35. PubMed ID: 23448570
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.